Cell culture is the process of growing cells outside their natural environment under controlled laboratory conditions. The cells and tissues thus obtained are used in different industries such as biotechnology, pharmaceuticals, and biopharmaceuticals. Cell culture was first employed by researchers in the early 1900s. This technique was also used to grow cell samples in vitro and was adopted in virology and vaccine production. It is one of the key tools used in molecular and cellular biology to study the physiology and biochemistry of cells (aging and metabolic studies), the effect of biomolecules and drugs on the cells, and carcinogenesis and mutagenesis studies. The major factor boosting market growth is the growing importance of this technology not only in the field of conventional research, but also in the development and production of vital biomolecules and therapeutics. Cell culture technology is applied in various medical sectors such as bioprocessing and manufacturing biologics, cell therapy, and regenerative medicines. On the other hand, factors such as stringent process controls that require advanced manufacturing capabilities and capacities, use of transgenic animals and plants, and ethical concerns over use of animal sources could negatively impact market growth.
Request a Sample Copy of the Report @ http://www.mrrse.com/sample/1525
The global cell culture market has been broadly segmented into media, sera, and reagents. Chemically-defined media rarely provide desired yield, and thus the inclination toward more complex media increases. The adoption of chemically-defined media has been slow yet steady for both media manufacturers and bioprocessors. Demand for media has been shifting from serum-based to serum-sparing, serum-free animal derived, and chemically-defined media. Lysogeny broth (LB) is a nutritive medium used for artificial bacteria growth.
The attachment factors segment accounted for the largest share of more than 25% of the global cell culture reagents market in 2014. However, amino acids is estimated to be the fastest growing segment during the forecast period from 2015 to 2023. The sera segment would witness sluggish growth due to the risk related to the protein and viral contamination and safety hazards related to the incorporation of serum from animal source which is driving the trend of serum-free media.
Inquiry on this report @ http://www.mrrse.com/enquiry/1525
Geographically, North America dominated the global cell culture market in 2014 and accounted for a share of over 40%. The dominance of this region was majorly due to favorable government policies fueling life sciences and stem cell research. Asia Pacific is expected to emerge as the fastest growing market during the forecast period from 2015 to 2023. An increase in the number of market participants from countries in Asia Pacific such as India, Japan, China, and Australia and recent trend of outsourcing research processes to emerging countries is likely to drive the market in this region.
Read Complete Report with TOC @ http://www.mrrse.com/cell-culture-media-sera-reagents-market
The global cell culture market is consolidated, comprising major players such as Sigma-Aldrich Corporation, BD Biosciences, EMD Millipore, Thermo Fisher Scientific, Inc., GE Healthcare, Lonza Biosciences, VWR International, and Corning Incorporated. High product differentiation plays a major role in determining the market position of these players. Large number of small players are entering the cell culture market, especially in emerging economies.
90 State Street,
Albany NY – 12207